🦸 Act 5 · The Hero — The Periodontist
Slide 1 / 4

🦸 F1 · The Hero Enters

The Periodontist — Gatekeeper, Enforcer, Systemic Guardian

The Periodontist Hero
🛡️

Gatekeeper

First line of defense. Detects disease before irreversible bone loss occurs. Risk profiling, early diagnosis, and screening in medically compromised patients — the periodontist intercepts the Villain before the Victim falls.

⚔️

Enforcer

Breaks the cycle of dysbiosis. Through scaling and root planing, biofilm disruption, and targeted antimicrobials, the Enforcer dismantles the Villain's stronghold — restoring microbial balance and resolving inflammation.

🌐

Systemic Guardian

Treats the mouth but protects the body. Periodontal therapy reduces HbA1c, lowers systemic IL-1β and TNF-α burden, and reduces adverse pregnancy outcomes. The periodontist's domain extends far beyond the sulcus.

🦸 F2 · The Hero's Strategy

Periodontal Treatment Cascade

1

Cause-Related Therapy

Active disease control — removing the Villain's weapons

  • Oral hygiene instructions (OHI) — toothbrushing technique, interdental cleaning, motivation
  • Scaling and root planing (SRP) — mechanical disruption and removal of subgingival biofilm and calculus
  • Risk factor modification — smoking cessation counselling, glycaemic control referral in diabetics
  • Local antimicrobials (chlorhexidine chips, minocycline microspheres) in deep pockets ≥5mm
  • Systemic antibiotics (metronidazole + amoxicillin) in Generalised Stage III/IV Grade C
2

Re-Evaluation

4–8 weeks post-SRP — assessing the battlefield

  • Full-mouth probing depth reassessment — documenting residual pockets
  • Bleeding on probing (BOP) — indicator of active inflammation
  • Clinical attachment level (CAL) changes vs baseline
  • Radiographic bone level comparison — vertical and horizontal patterns
  • Plaque score and compliance assessment
3

Corrective / Surgical Phase

Residual pockets ≥5mm — advanced intervention

  • Periodontal flap surgery — access for deep debridement
  • Osseous recontouring — correction of bony defects
  • Regenerative procedures: bone graft, GTR (guided tissue regeneration), Emdogain (Enamel Matrix Derivative)
4

Supportive Periodontal Therapy (SPT)

The real long-term battleground — maintenance and vigilance

  • 3–6 monthly recall intervals based on Stage and Grade
  • Supragingival prophylaxis and subgingival debridement at recall
  • Re-motivation and re-instruction of oral hygiene
  • Monitoring for disease recurrence — BOP, probing depths, radiographs
  • Lifelong commitment — SPT is not discharge, it is the maintenance phase of a chronic disease

⚗️ Host Modulation Therapy

Sub-Antimicrobial Doxycycline (SDD) — 20 mg BD; inhibits MMPs, reduces bone resorption; threaded through Phases 1–2
NSAIDs — topical ketorolac; block PGE₂ pathway locally
Bisphosphonates — adjunctive in severe Stage III/IV with systemic bone disease
Resolvins / SPMs — emerging; shift from suppression to active resolution of inflammation (bridges to F3)

🦸 F3 · The Story Continues

The Future of Periodontology

The Hero's tools are evolving. The next chapter of this story moves from suppressing disease to restoring health — from population averages to precision medicine, and from mechanical debridement to biological resolution.

🧬

Precision Periodontology

Personalised risk profiling based on genomic markers — IL-1 gene polymorphisms, TNF-α variants, and Fcγ receptor subtypes — identifies high-risk patients before clinical signs emerge. Salivary biomarkers (IL-1β, MMP-8) in chair-side diagnostic kits bring real-time biological monitoring to the operatory.

Genomics · Biomarkers
🦠

Microbiome Restoration

Rather than eliminating the biofilm, future therapy aims to restore symbiosis. Oral probiotics (L. reuteri, S. salivarius) re-establish commensals. Phage therapy selectively targets keystone pathogens — particularly P. gingivalis — without collateral microbial disruption.

Probiotics · Phage Therapy
💊

Resolution Biology & SPMs

Specialized Pro-resolving Mediators (SPMs) — Resolvins, Protectins, and Maresins — derived from omega-3 fatty acids, actively resolve inflammation rather than merely suppressing it. Van Dyke's work on lipoxins shifts the paradigm: the goal is not zero inflammation, but regulated resolution.

Resolvins · Lipoxins · Van Dyke
🤖

AI & Digital Periodontology

AI-assisted radiographic bone loss quantification delivers precision measurement at scale. Smart periodontal probes automate pocket charting, eliminating operator variability. Predictive risk models built on population-level data identify patients likely to progress before disease declares itself clinically.

AI Diagnostics · Smart Probes

🦸 F4 · Closing Chapter

The Story of Periodontal Disease — Told in Five Characters

The Narrative Arc — from Symbiosis to Resolution

🦠

The Villain

Dysbiotic
microbiome

🧬

The Victim

Host immune
response

⚔️

The Conflict

Bone loss &
tissue damage

🏛️

The Referee

Risk modifiers
tilt the scale

🦸

The Hero

Periodontist
restores health

🦠

The Villain

Dysbiosis is the origin — P. gingivalis as keystone pathogen subverts immunity to sustain the biofilm.

🧬

The Victim

The host is both sufferer and instrument — an exaggerated immune response destroys the very tissue it defends.

⚔️

The Conflict

Cytokines, MMPs, and RANKL drive bone destruction — inflammation unchecked becomes the weapon of mass tissue loss.

🏛️

The Referee

Risk modifiers — genetics, diabetes, smoking — decide who wins. Classification gives us the language to stage the fight.

🦸

The Hero

The periodontist dismantles the biofilm, modulates the host, and guards systemic health — one sulcus at a time.

"Periodontal disease is not merely a disease of the gingiva or the bone — it is a systemic war waged within the body, fuelled by microbial cunning and immunological excess. The periodontist does not simply treat a mouth. The periodontist ends the war."

Dr. Debasish Mishra, Associate Professor  ·  Dept. of Periodontology & Oral Implantology  ·  KIDS, KIIT Deemed to be University, Bhubaneswar